Chronic Rhinosinusitis

1061 Words3 Pages

For 8 weeks of vacation work I have been looking at preparing and characterizing nanoparticulate systems to encapsulate the antimicrobial drug mupirocin. Specifically polymeric nanoparticles and liposomes were investigated.

Chronic Rhinosinusitis (CRS) is an inflammatory disease of the nasal mucosa; often resulting from a Staphylococcus aureus (S. aureus), a bacterial infection in the sinus cavity (Suh JD. & Kennedy DW., 2011). S. aureus can be treated with antimicrobial mupiriocin (MUP). Nasal irrigation is employed for the current delivery of the drug, however the system lacks effectiveness. Copious amounts of solution need to be directed into the sinus cavity with majority of it pouring back out of the nose and hence decreasing the drugs efficacy. In addition to this, the planktonic bacteria in the cavity can amalgamate into biofilms; an exopolysaccharide matrix which is highly resistant to antimicrobials. These biofilms specifically require a novel drug delivery system in order to be successfully eradicated.

Antimicrobial encapsulated into polymeric nanoparticles is a suggested novel drug delivery system to treat CRS. Nanoparticles are categorized into nanospheres (matrix-like structure) and nanocapsules (vesicular systems). Nanospheres are a type of nanoparticles that allows drug encapsulation surrounded by a polymer matrix (Pinto Reis C. et al., 2006). Literature suggests Poly Lactic-co-Glycolic Acid (PLGA) is an attractive polymer to coat the nanospheres due to their biodegradable and biocompatible properties (Makadia HK. & Siegel SJ., 2011). The nanoprecipitation solvent-diffusion method was chosen for encapsulation of the poorly water-soluble drug MUP. Initially, an oil-in-water emulsion is formed. PLGA and MUP in a 1:1...

... middle of paper ...

....drugbank.ca/drugs/DB00410. [Accessed 03 February 14].
Makadia HK. & Siegel SJ., 2011. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers, 3, 1377-1397
Phoeung T., Morfin Huber L. & Lafleur M., 2009. Cationic Detergent/Sterol Mixtures Can Form Fluid Lamellar Phase and Stable Unilamellar Vesicles. Langmuir, 10, 5778-5784.
Pinto Reis C., Neufeld RJ., Ribeiro AJ., & Veiga F., 2006. Nanoencapsulation I. Method for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 2, 9-21
Suh JD. & Kennedy DW., 2011. Treatment Options for Chronic Rhinosinusitis. American Journal of Respiratory and Critical Care Medicine, 8, 132-140
Vemuri S. & Rhodes CT., 1994. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharmaceutics Acta Hebetiae, 70, 95-111.

More about Chronic Rhinosinusitis

Open Document